Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

CareDx Inc

CDNA
18,92
0,02 (0,11%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/2/202522:09EDGAR2Form 8-K - Current report
26/2/202522:05BWCareDx Announces Fourth Quarter and Full Year 2024 Financial..
25/2/202513:05BWCareDx Announces District Court Reverses Jury Decision in..
21/2/202503:13BWCareDxが研究結果を発表、AlloSeq cfDNAが臓器移植患者の拒絶反応検出に高い精度を示す
20/2/202523:31BWCareDx publie une étude confirmant la grande précision..
20/2/202522:03BWCareDx gibt Studie bekannt, die zeigt, dass AlloSeq cfDNA..
20/2/202513:05BWCareDx Announces Study Showing AlloSeq cfDNA Highly Accurate..
14/2/202517:23EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
13/2/202513:05BWCareDx Announces Presentation of Data at 2025 Tandem..
11/2/202513:05BWCareDx to Report Fourth Quarter and Full Year 2024 Financial..
07/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202503:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:18EDGAR2Form 144 - Report of proposed sale of securities
13/1/202513:00BWCareDx Announces Preliminary Fourth Quarter and Full Year..
08/1/202522:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202522:30EDGAR2Form 8-K - Current report
18/12/202413:05BWCareDx to Participate in the 43rd Annual J.P. Morgan..
11/12/202413:00PRNUSTCBP Partners with CareDx to Support ACHIEVE Clinical Trial..
06/12/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:42EDGAR2Form 144 - Report of proposed sale of securities
04/12/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:25EDGAR2Form 144 - Report of proposed sale of securities
25/11/202422:45EDGAR2Form 144 - Report of proposed sale of securities
18/11/202423:11EDGAR2Form 144 - Report of proposed sale of securities
18/11/202413:00BWGestion mondiale d’actifs CI annonce un nombre de fusions de..
14/11/202423:13EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202413:05BWCareDx to Participate in Upcoming Investor Conferences
08/11/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202420:34EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
05/11/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202412:07EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
04/11/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202422:10EDGAR2Form 8-K - Current report
04/11/202422:05BWCareDx Reports Third Quarter 2024 Results and Raises Revenue..
23/10/202413:00BWCareDx and Dovetail Genomics Announce Strategic Partnership..
21/10/202413:00BWCareDx Showcases Latest Advancements Across its HLA Typing..
15/10/202413:56EDGAR2Form 8-K - Current report
15/10/202412:00BWCareDx Reports Preliminary Financial Results for Third..
11/10/202422:30BWCareDx Reports Inducement Grant Under Nasdaq Listing Rule..
09/10/202413:05BWCareDx Appoints Jing Huang Chief Data and AI Officer
08/10/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202422:05BWCareDx to Host Investor Day on October 15, 2024
08/10/202416:00EDGAR2Form 8-K - Current report
08/10/202412:05BWCareDx Announces Closure of DOJ Investigation with No..
04/10/202422:05EDGAR2Form 8-K - Current report
16/9/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 18,765 Min: 18,12 Max: 19,1591
Chiusura: 18,90

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network